US Broker Ratings

CG Oncology, Inc. (CGON) Stock Analysis: A 55% Upside Potential in the Biotech Sector

CG Oncology, Inc. (NASDAQ: CGON), a promising player in the biotechnology sector, is capturing the attention of investors with a compelling storyline of innovation and potential growth. Specializing in bladder-sparing..

Kiniksa Pharmaceuticals Interna (KNSA) Investor Outlook: Eyeing a 21% Upside with Strong Buy Ratings

Kiniksa Pharmaceuticals Interna (NASDAQ: KNSA) has been capturing the attention of investors with its compelling growth story and impressive market performance. As a prominent player in the healthcare sector, specifically..

Beam Therapeutics Inc. (BEAM) Stock Analysis: Unlocking a 69% Potential Upside in Genetic Medicine

Beam Therapeutics Inc. (NASDAQ: BEAM) stands at the forefront of the biotechnology sector, focusing on precision genetic medicines aimed at treating serious diseases. With a market capitalization of $2.83 billion,..

NovoCure Limited (NVCR) Stock Analysis: Unveiling a 129% Upside Potential in the Tumor Treating Fields Market

NovoCure Limited (NVCR) is a compelling player in the healthcare sector, specifically within the medical devices industry. With its headquarters in Baar, Switzerland, NovoCure is at the forefront of developing..

Schrodinger, Inc. (SDGR) Investor Outlook: Unpacking a 123% Potential Upside

Schrodinger, Inc. (SDGR) stands at the crossroads of technology and healthcare, offering a compelling investment opportunity in the health information services industry. Based in New York, the company specializes in..

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: Potential 41.67% Upside Amid Robust CNS Drug Portfolio

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a key player in the biotechnology sector, is drawing attention from investors with an impressive projected upside of 41.67% based on analyst target prices. With..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A High-Potential Biotech Play with 27% Upside

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is a burgeoning player in the biotechnology sector, capturing investor interest with its innovative approach to treating muscle disorders. Headquartered in Boulder, Colorado, this biopharmaceutical..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Unveiling a 15% Potential Upside in the Senior Living Sector

Brookdale Senior Living Inc. (BKD), a prominent player in the healthcare sector focused on medical care facilities, has been making waves with its promising stock performance and growth potential. As..

Select Medical Holdings Corp (SEM) Stock Analysis: 12.33% Potential Upside in Healthcare Sector

Select Medical Holdings Corporation (NYSE: SEM) presents a noteworthy opportunity for investors seeking exposure to the healthcare sector, particularly within the medical care facilities industry. With a current market capitalization..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a Promising 20.64% Potential Upside

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a leading player in the healthcare sector, specifically within the specialty and generic drug manufacturing industry, is garnering attention from investors due to its promising..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unpacking a 52.25% Potential Upside

Travere Therapeutics, Inc. (NASDAQ: TVTX) is making waves in the biopharmaceutical sector, particularly for investors looking at biotechnology as a fertile ground for growth. With a market capitalization of $2.49..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Eye-Catching 52% Upside Potential Sparks Investor Interest

Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS), a burgeoning name in the biotechnology sector, is attracting attention from investors with its promising portfolio of eye care therapeutics and a compelling growth potential...

Metsera, Inc. (MTSR) Stock Analysis: Navigating a Clinical-Stage Biotech with a -19.15% Potential Downside

Metsera, Inc. (NASDAQ: MTSR), a clinical-stage biotechnology company, is at the forefront of developing innovative solutions for obesity and related diseases. Despite its promising pipeline, investors should carefully weigh the..

National HealthCare Corporation (NHC) Stock Analysis: Strong Revenue Growth Amid Uncertain Valuations

National HealthCare Corporation (NHC), a prominent player in the healthcare sector, has been steadily climbing the market ladder with its diverse range of services. With a market cap of $2.63..

Tandem Diabetes Care, Inc. (TNDM) Investor Outlook: Exploring a 37.96% Potential Upside

Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a prominent player in the healthcare sector, specializes in medical devices, particularly those catering to diabetes management. With a market capitalization of $1.28 billion,..

Sotera Health Company (SHC) Stock Analysis: A Promising 19.38% Potential Upside Captures Investor Attention

Sotera Health Company (NASDAQ: SHC) is garnering significant interest from investors, thanks to its robust position in the healthcare sector and an impressive potential upside of 19.38%. With its focus..

Organon & Co. (OGN) Stock Analysis: Evaluating a Potential 24.69% Upside in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may find Organon & Co. (NYSE: OGN) an intriguing prospect. Despite facing certain challenges, the company’s stock analysis reveals potential upside, making it..

Arcutis Biotherapeutics, Inc. (ARQT)

⚠️ No article content returned.

..

Arcellx, Inc. (ACLX) Stock Analysis: Exploring a 61% Potential Upside with Strong Buy Ratings

Arcellx, Inc. (NASDAQ: ACLX) is capturing the attention of investors with its promising biotechnology ventures and impressive analyst ratings. Operating in the healthcare sector, Arcellx is a United States-based company..

Xenon Pharmaceuticals Inc. (XENE): Investor Outlook on a Promising 34.69% Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (XENE), a Canadian biotechnology firm, is capturing investor attention with a compelling blend of scientific innovation and market potential. Specializing in the development of therapeutics for neurological..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds